Vitamin D and cardiovascular disease

Anticancer Research

Volumn 34, Issue 9, 2014, Pages 4641-4648

  Zittermann, Armin ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

1,25 dihydroxyvitamin D, cardiovascular disease; 25 hydroxyvitamin D; Review; Vascular calcification; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN II; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; RENIN; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

BLOOD VESSEL CALCIFICATION; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOFT TISSUE CALCIFICATION; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN SUPPLEMENTATION; ANIMAL; METABOLISM; RISK FACTOR;

1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; CARDIOVASCULAR DISEASE; REVIEW; VASCULAR CALCIFICATION; VITAMIN D;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84908681865     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ and Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58, 2011.
2. Zittermann A: Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92: 39-48, 2006.
3. Jahreis G and Hesse V: Vitamin D-induced tissue calcinosis and arteriosclerosis changes. I: A contribution to the 60 year history of vitamin D research with special reference to childhood. Padiatr Grenzgeb 29: 203-211, 1990 [In German].
4. Kobylinski S, Hafer B and Kohde G: Correlative pathologic studies on the role of vitamin D in vascular calcinosis in childhood. Zentralbl Allg Pathol 129: 137-147, 1984 [In German].
5. Scragg R: Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 10: 337-341, 1981.
6. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R and Demer LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760, 1997.
7. Zittermann A, Schleithoff SS and Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94: 483-492, 2005.
8. Huybers S and Bindels RJ: Vascular calcification in chronic kidney disease: new developments in drug therapy. Kidney International 72: 663-665, 2007.
9. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Giummelly P and Atkinson J: Calcification of medial elastic fibers and aortic elasticity. Hypertension 29: 999-1006, 1997.
10. Price PA, Buckley JR and Williamson MK: The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131: 2910-2915, 2001.
11. Rebsamen MC, Sun J, Norman AW and Liao JK: 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91: 17-24, 2002.
12. Bas A, Lopez I, Perez J, Rodriguez M and Aguilera-Tejero E: Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 21: 484-490, 2006.
13. Stubbs JR, Liu S, Tang W, Zhou J, Wang Y, Yao X and Quarles LD: Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18: 2116-2214, 2007.
14. Razzaque MS: The dualistic role of vitamin D in vascular calcifications. Kidney Int 79: 708-714, 2011.
15. Tuohimaa P: Vitamin D and aging. J Steroid Biochem Mol Biol 114: 78-84, 2009.
16. Tamagaki K, Yuan Q, Ohkawa H, Imazeki I, Moriguchi Y, Imai N, Sasaki S, Takeda K and Fukagawa M: Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 21: 651-659, 2009.
17. Dusso A1, Arcidiacono MV, Yang J and Tokumoto M: Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality. J Steroid Biochem Mol Biol 121: 193-198, 2010.
18. Schmidt N, Brandsch C, Kühne H, Thiele A, Hirche F and Stangl GI: Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 7: e35316, 2012.
19. Ellam T, Hameed A, ul Haque R, Muthana M, Wilkie M, Francis SE and Chico TJ: Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice. PLoS One 9: e88767, 2014.
20. Li YC1, Kong J, Wei M, Chen ZF, Liu SQ and Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238, 2002.
21. Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y and Gardner DG: Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124: 1838-1847, 2011.
22. 2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120: 687-698, 2009.
23. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL and Sesso HD: Circulating 25-hydroxyvitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5: 819-829, 2012.
24. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF and Börgermann J: Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J 34: 1358-1364, 2013.
25. Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD and Feldman BS: Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 98: 2160-2167, 2013.
26. Gotsman I, Shauer A, Zwas DR, Hellman Y, Keren A, Lotan C and Admon D: Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail 14: 357-366, 2012.
27. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D and Howard PA: Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 109: 359-363, 2012.
28. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H and Koerfer R: Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89: 1321-1327, 2009.
29. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF and Zhu H: A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 95: 4584-4591, 2010.
30. Shab-Bidar S, Neyestani TR and Djazayery A: Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord 11: 12, 2011.
31. Kharlamov AN, Perrish AN, GabiskiѤ IaL, Ronne Kh and Ivanova E: Vitamin D in the treatment of cardiorenal syndrome in patients with chronic nephropathy. Kardiologiia 52: 33-44, 2012 [Article in Russian].
32. Longenecker CT1, Hileman CO, Carman TL, Ross AC, Seydafkan S, Brown TT, Labbato DE, Storer N, Tangpricha V and McComsey GA: Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 17: 613-621, 2012.
33. Gepner AD1, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N and Stein JH: A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 7: e36617, 2012.
34. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM and Macdonald HM: Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 97: 3557-3568, 2012.
35. Muldowney S, Lucey AJ, Hill TR, Seamans KM, Taylor N, Wallace JM, Horigan G, Barnes MS, Bonham MP, Duffy EM, Strain JJ, Cashman KD and Kiely M: Incremental cholecalciferol supplementation up to 15 μg/d throughout winter at 51-55° N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. J Nutr 142: 1519-1525, 2012.
36. Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Hoshiarrad A and Gohari M: Vitamin D 3 and the risk of CVD in overweight and obese women: a randomised controlled trial. Br J Nutr 108: 1866-1873, 2012.
37. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Lau CP, Cheung BM and Tse HF: Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227: 140-146, 2013.
38. Sugden JA, Davies JI, Witham MD, Morris AD and Struthers AD: Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25: 320-325, 2008.
39. Tarcin O1, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O and Akalin S: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94: 4023-4030, 2009.
40. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD and Struthers AD: The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53: 2112-2119, 2010.
41. Jorde R, Sneve M, Torjesen P and Figenschau Y: No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 267: 462-472, 2010.
42. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, Shah Y, Zhu H and Dong Y: Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24: 557-562, 2011.
43. Scragg R, Wishart J, Stewart A, Ofanoa M, Kerse N, Dyall L and Lawes CM: No effect of ultraviolet radiation on blood pressure and other cardiovascular risk factors. J Hypertens 29: 1749-1756, 2011.
44. Witham MD, Dove FJ, Sugden JA, Doney AS and Struthers AD: The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 22: 864-870, 2012.
45. Stricker H, Tosi Bianda F, Guidicelli-Nicolosi S, Limoni C and Colucci G: Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 44: 307-312, 2012.
46. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH, Yu Y, Gupta AK and Alderman MH: The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med 17: 394-404, 2012.
47. Ponda MP, Dowd K, Finkielstein D, Holt PR and Breslow JL: The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 32: 2510-2515, 2012.
48. Witham MD, Dove FJ, Khan F, Lang CC, Belch JJ and Struthers AD: Effects of vitamin D supplementation on markers of vascular function after myocardial infarction - a randomised controlled trial. Int J Cardiol 167: 745-749, 2013.
49. Witham MD, Adams F, Kabir G, Kennedy G, Belch JJ and Khan F: Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - a randomised controlled trial. Atherosclerosis 230: 293-299, 2013.
50. Rahimi-Ardabili H1, Pourghassem Gargari B and Farzadi L: Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest 36: 28-32, 2013.
51. Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, Macdonald TM, Mackenzie IS and Struthers AD: Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 63: 706-712, 2014.
52. Jorde R, Strand Hutchinson M, Kjærgaard M, Sneve M and Grimnes G: Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø. ISRN Endocrinol 2013: 348705, 2013.
53. Thompson AM1, Hu T, Eshelbrenner CL, Reynolds K, He J and Bazzano LA: Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA 305: 913-22, 2011.
54. Witham MD, Nadir MA and Struthers AD: Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27: 1948-1954, 2009.
55. Kunutsor SK, Burgess S, Munroe PB and Khan H: Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol 29: 1-14, 2014.
56. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M and Gluud C: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1: CD007470. doi: 10.1002/14651858, 2014.
57. Bolland MJ, Grey A, Gamble GD and Reid IR: The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2: 307-320, 2014.
58. Avenell A1, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA and RECORD Trial Group: Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 97: 614-622, 2012.
59. Grimes DS: Are statins analogues of vitamin D? Lancet 368: 83-86, 2006.
60. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD and Reid IR: Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341: c3691, 2010.
61. Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH and Park Y: Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 173: 639-646, 2013.
62. Michaëlsson K, Melhus H, Warensjö Lemming E, Wolk A and Byberg L: Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 346: f228, 2013.
63. Wang L, Manson JE, Song Y and Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152: 315-323, 2010.
64. Zittermann A, Börgermann J, Gummert JF and Pilz S: Future directions in vitamin D and cardiovascular research. Nutr Metab Cardiovasc Dis 22: 541-546, 2012.
65. Kupferschmidt K: Uncertain verdict as vitamin D goes on trial. Science 337: 1476-1478, 2012.
66. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D and Nicholson GC: Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303: 1815-1822, 2010.
67. Rossini M, Adami S, Viapiana O, Fracassi E, Idolazzi L, Povino MR and Gatti D: Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers. Calcif Tissue Int 91: 365-369, 2012.
68. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R and Dawson-Hughes B: A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367: 40-49, 2012.